Dr. Okada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1450 3rd Street
San Francisco, CA 94158Phone+1 415-476-1637
Education & Training
- Nagoya University - School of MedicineClass of 1991
Certifications & Licensure
- PA State Medical License 2004 - 2014
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Clinical Trials
- H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas Start of enrollment: 2016 Nov 18
Publications & Presentations
PubMed
- 280 citationsIsocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomasGary Kohanbash, Diego Carrera, Shruti Shrivastav, Brian Ahn, Naznin Jahan
The Journal of Clinical Investigation. 2017-04-03 - 420 citationsInduction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells...Hideho Okada, Pawel Kalinski, Ryo Ueda, Aki Hoji, Gary Kohanbash
Journal of Clinical Oncology. 2011-01-20 - 1129 citationsA single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.Donald M. O'Rourke, MacLean Nasrallah, Arati Desai, J. Joseph Melenhorst, Keith Mansfield
Science Translational Medicine. 2017-07-19
Journal Articles
- Immunotherapy of Primary Brain Tumors: Facts and HopesHideho Okada, MD, Clinical Cancer Research
- Single-Cell Profiling of Human Gliomas Reveals Macrophage Ontogeny as a Basis for Regional Differences in Macrophage Activation in the Tumor MicroenvironmentDaniel A Lim, S John Liu, Manish Aghi, Hideho Okada, Nduka M Amankulor, Arnold R Kriegstein, BioMed Central
Press Mentions
- Next-Generation T-cell Therapeutics Set Sights on Cancers, Autoimmune Disorders and MoreJune 17th, 2021
- Engineered Immune Cells Eliminate Brain Cancer in MiceMay 25th, 2021
- Smart Cell Therapies for Solid Cancers Ready to Move Toward Clinical TrialsApril 28th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: